drugset
drugset / Trial / NCT02688101

Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors

NCT02688101 ↗

Phase 1 Completed 14 enrolled Collaborative Medicinal Development Pty Limited
NaSingle-groupOpen-labelTreatment

Summary

Multicenter, open-label, dose-escalation and pharmacokinetic study.

Timeline

Start
2016-04-11
Primary completion
2017-10-26
Completion
2017-10-26

Drugs

EvaluationDrugModalityDoseRoute
Subject DpC Unknown — Oral

Indications

neoplasm